Literature DB >> 34497402

Epidemiology of cardiovascular disease in Europe.

Nick Townsend1, Denis Kazakiewicz2, F Lucy Wright3, Adam Timmis2,4, Radu Huculeci2, Aleksandra Torbica5, Chris P Gale6, Stephan Achenbach2, Franz Weidinger2, Panos Vardas2.   

Abstract

This Review presents data describing the health burden of cardiovascular disease (CVD) within and across the WHO European Region. CVD remains the most common cause of death in the region. Deaths from CVD in those aged <70 years, commonly referred to as premature, are a particular concern, with >60 million potential years of life lost to CVD in Europe annually. Although more women than men die from CVD, age-standardized rates of both morbidity and death are higher in men, and these differences in rates are greatest in individuals aged <70 years. Large inequalities in all measures of morbidity, treatment and mortality can be found between countries across the continent and must be a focus for improving health. Large differences also exist in the data available between countries. The development and implementation of evidence-based preventive and treatment approaches must be supported in all countries by consistent surveillance and monitoring, such that we can quantify the health burden of CVD as well as target interventions and provide impetus for action across Europe.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34497402     DOI: 10.1038/s41569-021-00607-3

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  38 in total

1.  Cardiovascular disease in Europe: epidemiological update 2016.

Authors:  Nick Townsend; Lauren Wilson; Prachi Bhatnagar; Kremlin Wickramasinghe; Mike Rayner; Melanie Nichols
Journal:  Eur Heart J       Date:  2016-08-14       Impact factor: 29.983

2.  Epidemiology of cardiovascular disease: the new ESC Atlas and beyond.

Authors:  Thomas F Lüscher
Journal:  Eur Heart J       Date:  2018-02-14       Impact factor: 29.983

3.  Cardiovascular disease in Europe 2014: epidemiological update.

Authors:  Melanie Nichols; Nick Townsend; Peter Scarborough; Mike Rayner
Journal:  Eur Heart J       Date:  2014-08-19       Impact factor: 29.983

4.  Cardiovascular disease in Europe--epidemiological update 2015.

Authors:  Nick Townsend; Melanie Nichols; Peter Scarborough; Mike Rayner
Journal:  Eur Heart J       Date:  2015-08-25       Impact factor: 29.983

5.  European Society of Cardiology: Cardiovascular Disease Statistics 2017.

Authors:  Adam Timmis; Nick Townsend; Chris Gale; Rick Grobbee; Nikos Maniadakis; Marcus Flather; Elizabeth Wilkins; Lucy Wright; Rimke Vos; Jeroen Bax; Maxim Blum; Fausto Pinto; Panos Vardas
Journal:  Eur Heart J       Date:  2018-02-14       Impact factor: 29.983

6.  European Society of Cardiology: Cardiovascular Disease Statistics 2019.

Authors:  Adam Timmis; Nick Townsend; Chris P Gale; Aleksandra Torbica; Maddalena Lettino; Steffen E Petersen; Elias A Mossialos; Aldo P Maggioni; Dzianis Kazakiewicz; Heidi T May; Delphine De Smedt; Marcus Flather; Liesl Zuhlke; John F Beltrame; Radu Huculeci; Luigi Tavazzi; Gerhard Hindricks; Jeroen Bax; Barbara Casadei; Stephan Achenbach; Lucy Wright; Panos Vardas
Journal:  Eur Heart J       Date:  2020-01-01       Impact factor: 29.983

7.  Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009.

Authors:  Melanie Nichols; Nick Townsend; Peter Scarborough; Mike Rayner
Journal:  Eur Heart J       Date:  2013-06-25       Impact factor: 29.983

8.  Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983-2013: joinpoint regression analysis.

Authors:  Lauren Wilson; Prachi Bhatnagar; Nick Townsend
Journal:  Popul Health Metr       Date:  2017-07-01

9.  Examining trends in cardiovascular disease mortality across Europe: how does the introduction of a new European Standard Population affect the description of the relative burden of cardiovascular disease?

Authors:  Shiva Tadayon; Kremlin Wickramasinghe; Nick Townsend
Journal:  Popul Health Metr       Date:  2019-05-30

10.  Epidemiology report: trends in sex-specific cerebrovascular disease mortality in Europe based on WHO mortality data.

Authors:  Rushabh Shah; Elizabeth Wilkins; Melanie Nichols; Paul Kelly; Farah El-Sadi; F Lucy Wright; Nick Townsend
Journal:  Eur Heart J       Date:  2019-03-01       Impact factor: 29.983

View more
  17 in total

Review 1.  Epoxylipids and soluble epoxide hydrolase in heart diseases.

Authors:  John D Imig; Ludek Cervenka; Jan Neckar
Journal:  Biochem Pharmacol       Date:  2021-12-02       Impact factor: 5.858

Review 2.  The effect of allopurinol on cardiovascular outcomes in patients with type 2 diabetes: a systematic review.

Authors:  Evanthia Bletsa; Stavroula A Paschou; Vasiliki Tsigkou; Panagiota K Stampouloglou; Vasiliki Vasileiou; Georgia N Kassi; Evangelos Oikonomou; Gerasimos Siasos
Journal:  Hormones (Athens)       Date:  2022-10-05       Impact factor: 3.419

Review 3.  Biomarkers of Volume Overload and Edema in Heart Failure With Reduced Ejection Fraction.

Authors:  Roxana Mihaela Chiorescu; Roxana-Daiana Lazar; Sándor-Botond Buksa; Mihaela Mocan; Dan Blendea
Journal:  Front Cardiovasc Med       Date:  2022-06-17

Review 4.  The Continuum of Invasive Techniques for the Assessment of Intermediate Coronary Lesions.

Authors:  Nicoleta-Monica Popa-Fotea; Alexandru Scafa-Udriste; Maria Dorobantu
Journal:  Diagnostics (Basel)       Date:  2022-06-18

Review 5.  Polyphenols: a route from bioavailability to bioactivity addressing potential health benefits to tackle human chronic diseases.

Authors:  Silvia Vivarelli; Chiara Costa; Michele Teodoro; Federica Giambò; Aristidis Michael Tsatsakis; Concettina Fenga
Journal:  Arch Toxicol       Date:  2022-10-19       Impact factor: 6.168

Review 6.  A Systematic Review and Meta-Analysis of the Efficacy and Safety of Xinbao Pill in Chronic Heart Failure.

Authors:  Yuanping Wang; Yuntao Liu; Zhongqiu Liu; Yuanyuan Cheng; Dawei Wang
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

7.  Socioeconomic inequalities in physiological risk biomarkers and the role of lifestyles among Russians aged 35-69 years.

Authors:  Sergi Trias-Llimós; Sarah Cook; Anne Elise Eggen; Alexander V Kudryavtsev; Sofia Malyutina; Vladimir M Shkolnikov; David A Leon
Journal:  Int J Equity Health       Date:  2022-04-15

Review 8.  Progress and Setbacks in Translating a Decade of Ferroptosis Research into Clinical Practice.

Authors:  Friedrich Alexander von Samson-Himmelstjerna; Benedikt Kolbrink; Theresa Riebeling; Ulrich Kunzendorf; Stefan Krautwald
Journal:  Cells       Date:  2022-07-06       Impact factor: 7.666

9.  The Association Between Psoriasis and Risk of Cardiovascular Disease: A Mendelian Randomization Analysis.

Authors:  Ning Gao; Minjian Kong; Xuebiao Li; Xian Zhu; Dongdong Wei; Ming Ni; Yifan Wang; Ze Hong; Aiqiang Dong
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

10.  CRISPR/dCas9 Transcriptional Activation of Endogenous Apolipoprotein AI and Paraoxonase 1 in Enterocytes Alleviates Endothelial Cell Dysfunction.

Authors:  Laura Toma; Teodora Barbălată; Gabriela M Sanda; Loredan S Niculescu; Anca V Sima; Camelia S Stancu
Journal:  Biomolecules       Date:  2021-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.